Trial Profile
Analysis of the effect and side effects of desmopressin melt in patients with nocturnal polyuria.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2017
Price :
$35
*
At a glance
- Drugs Desmopressin (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- 05 Aug 2017 Status changed from recruiting to discontinued.
- 18 Jul 2012 New trial record